TB500 10mg
$59.99
TB500 10mg
Thymosin Beta-4
CAS: 77591-33-4
TB-500 (Thymosin Beta-4) 10mg — the deep recovery layer. G-actin sequestering peptide for tissue repair and inflammation modulation.
For research purposes only. Not intended for human use.
G-Actin Sequestration, Cell Migration, and Anti-Inflammatory Signaling
Thymosin Beta-4 (TB-500) sequesters approximately 40-50% of cellular G-actin (monomeric actin), regulating the pool available for controlled polymerization. By modulating actin dynamics, TB-500 controls cell migration — directing fibroblasts, endothelial cells, and stem cells into wound zones for organized tissue repair. Secondary mechanisms include TNF-alpha and IL-6 downregulation (anti-inflammatory) and VEGF upregulation (angiogenesis). Often combined with BPC-157 for the full Clav stack recovery protocol.
G-Actin Regulation
TB-500's primary mechanism is G-actin sequestration — approximately 40-50% of cellular G-actin is bound by thymosin Beta-4. This modulates the dynamics of actin polymerization, controlling the rate and organization of cell migration during tissue repair.
Connective Tissue Support
During aggressive body recomposition, connective tissues adapt to changing body mechanics and training loads. TB-500's connective tissue repair research covers tendons, ligaments, and fascia — supporting the structural demands of a recomposition protocol.
BPC-157 + TB-500: The Recovery Stack
BPC-157 addresses gastric/mucosal protection and angiogenesis via VEGFR2. TB-500 addresses systemic tissue repair via G-actin modulation. Different mechanisms, complementary coverage — frequently co-administered in recovery protocols.
Specifications
Research FAQ
Can TB-500 and BPC-157 be combined?
Yes — frequently co-administered. BPC-157 covers gastric/mucosal protection via NO system and VEGFR2. TB-500 addresses systemic connective tissue repair via G-actin modulation. Different mechanisms, fully complementary.
